(Total Views: 867)
Posted On: 11/02/2020 7:32:29 PM
Post# of 155566
November 2, 2020
Regeneron, Lilly Setbacks Raise Questions on the Effectiveness of Antibodies in Severe COVID-19
https://www.genengnews.com/news/regeneron-lil...5551289H0I
Humanigen Announces First Patient Dosed in NIH ACTIV-5/Big Effect Trial Evaluating Lenzilumabâ„¢ for COVID
NeuroRX Submits Request for Emergency Use Authorization for RLF-100 in Treatment of COVID-19 Patients with Respiratory Failure & No Other Recourse
Regeneron, Lilly Setbacks Raise Questions on the Effectiveness of Antibodies in Severe COVID-19
https://www.genengnews.com/news/regeneron-lil...5551289H0I
Humanigen Announces First Patient Dosed in NIH ACTIV-5/Big Effect Trial Evaluating Lenzilumabâ„¢ for COVID
NeuroRX Submits Request for Emergency Use Authorization for RLF-100 in Treatment of COVID-19 Patients with Respiratory Failure & No Other Recourse
(1)
(0)
